Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
64 participants
INTERVENTIONAL
2024-12-01
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of kınesıologıcal tapıng, mobılızatıon and breathıng exercıse on paın and Comfort After Caesarea
NCT06201143
Rotation and Movement System, Postpartum Cesarean Sections
NCT05499208
Kinesio Taping Application After Cesarean Section
NCT05213975
The Effect of Progressive Relaxation Exercises on Physiological Parameters, Pain and Anxiety After Cesarean Section
NCT06294717
Deep Tissue Massage on Pain and Comfort After Cesarean
NCT04457921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
The first interview with the intervention group patients will be held when the patients arrive at the hospital. In these interviews, the patients will first be introduced to the patients, detailed information will be provided about the research, their verbal/written informed consent will be obtained, and answers will be obtained to the questions in the patient information form. In addition, the content of the early mobilization training given to the patients in the first interview, what early mobilization is, why it is important, what benefits it provides, what the mobilization goals determined for the patient within the scope of the research are, the benefits of walking and the expected results will be explained. It will be explained how to benefit from the smartphone during the mobilization process. In addition to all the training, the patients in the intervention group will be given detailed information about what they need to record in the mobilization diary (total time they walke
mobilization training and targeted mobilization
In the first interview with the patients, the content of the early mobilization training given to the patients, what early mobilization is, why it is important, what benefits it provides, what the mobilization goals determined for the patient within the scope of the research, the benefits of walking and the expected results will be explained. It will be explained how to benefit from the smartphone during the mobilization process. In addition to all the training, the patients in the intervention group will be given detailed information about what they need to record in the mobilization diary (total time they walked, how many steps they took in the pedometer application after each mobilization, positive/negative situations they experienced while standing up and walking) and all the forms that will be used in the data collection phase.
control group
Women in the control group will be left to the routine care of the institution. Within the scope of routine care, women in this group will be asked to record their walking distance.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mobilization training and targeted mobilization
In the first interview with the patients, the content of the early mobilization training given to the patients, what early mobilization is, why it is important, what benefits it provides, what the mobilization goals determined for the patient within the scope of the research, the benefits of walking and the expected results will be explained. It will be explained how to benefit from the smartphone during the mobilization process. In addition to all the training, the patients in the intervention group will be given detailed information about what they need to record in the mobilization diary (total time they walked, how many steps they took in the pedometer application after each mobilization, positive/negative situations they experienced while standing up and walking) and all the forms that will be used in the data collection phase.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least primary school graduate,
* Giving birth at term
* Having a live singleton pregnancy,
* No risky pregnancy history (DVT, thromboembolism)
* Women who can use a mobile phone
Exclusion Criteria
* Undergoing emergency caesarean section,
* Not recording walking distance
* Women who cannot be interviewed within 24 hours of discharge
* Women who develop maternal or neonatal complications after birth
18 Months
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nigde Omer Halisdemir University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
isa temur, Dr
Role: PRINCIPAL_INVESTIGATOR
NİĞDE ÖMER HALİSDEMİR UNIVERCITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Niğde Ömer Halisdemir Univercity
Niğde, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22504254-050.04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.